FDA Import Refusal 1FX-8403939-4/10002/1 — NOVO NORDISK GLOBAL BUSINESS SER
The FDA refused shipment 1FX-8403939-4/10002/1 from NOVO NORDISK GLOBAL BUSINESS SER (India) on May 27, 2026. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charges: 118,75
Refusal Details
- Date
- May 27, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 118,75